Earlybird Venture Capital

The J.P. Morgan Healthcare Conference held in San Francisco, CA has a stellar reputation. Yet what about a similar event to activate Europe’s health and life science investment community? We see the Jefferies conference as an excellent answer here, where the community gathers to exchange – often outside the official venue. Side events have also become increasingly important at such major events, where people head to cafes or schedule meetings to interact with peers and ultimately back more innovation! Earlybird Health teammates including Dr. Christoph Massner, Rabab Nasrallah, PhD, Junkai Z., and Florent Gros Earlybird had a great experience in London at Jefferies –  a lot closer to home compared to SF. Nice to connect with Leaps by Bayer, LifeSci Partners, European Healthcare Investor Association (E.H.I.A.), Goodwin, British Patient Capital, Oppenheimer & Co. Inc., Cooley LLP, Osborne Clarke. #Health #LifeScience #VC #Investment #Europe #Jefferieshealthcare Cc: Thom Rasche, Greywolf Therapeutics, & more.

💫 Two years after OpenAI launched ChatGPT, the global AI landscape has shifted dramatically, and it's clear this technology is more than a buzzword. AI is already reshaping industries: generating photorealistic images, improving autonomous driving, and enabling robots to learn through imitation. But here’s the challenge: much of the transformative AI we see today is driven by U.S. tech giants, like OpenAI, Google, and NVIDIA. 🌍 So, how can Germany leverage its existing strengths and carve out competitive niches in the global AI race? A recent Handelsblatt article explored the competitiveness of German AI startups compared to their U.S. counterparts. 👉 Earlybird Partner Dr. Andre Retterath., featured in the article, made a compelling point:"In the hype around AI, one quickly gets the impression that the exciting companies are only those with huge funding from prominent investors. I consider that to be a misconception." Despite the funding gap between American and German startups, the article emphasizes a promising path forward for Germany – one that doesn’t require direct competition with thriving U.S. tech giants. By focusing on niche applications and tailored business solutions, Germany has the potential to lead in key areas of AI innovation. The future of AI isn’t just about scale; it’s about relevance. Read more here (🇩🇪): https://bit.ly/3CO5cDg Cc: Luisa Bomke, Lina Sophie Knees, Larissa Holzki, Akash Bajwa, Laurin Class, Elisheva Marcus, Jonas Andrulis, Aleph Alpha #AI #KI #Investment #VC #AIstartups #EuropeanTech

Yesterday, Earlybird Health's biopharma portfolio company ImCheck Therapeutics presented encouraging interim results from its Phase I/II EVICTION study at the 66th American Society of Hematology Annual Meeting. 🔑 Key findings: ICT01 demonstrated a favorable safety and tolerability profile across both low and high dose levels. Notably, it achieved high rates of complete remission (CR) and composite CR across diverse molecular subgroups, with particularly encouraging outcomes in TP53-mutated AML—a subgroup associated with poor prognosis. Join the poster presentation live on Dec 8, 2024, in San Diego, or stay tuned to ImCheck’s website for the online poster, available soon!  🔗 More on the press release at: https://lnkd.in/eNuP__ej #EBVCgang #Biopharma #AML #ASH2024

Born in Berlin, motivated by a mission, and with early backing by Earlybird, startup Deed now turns individual good deeds into enterprise-wide initiatives. 🌍 We look for companies on a mission to make a global impact, and Deed does exactly that. Deed partners with companies around the world, providing access to over 2 million global nonprofits. Fast forward to today, Deed has headquarters in Berlin, New York, and San Francisco. What started as a viral giving and volunteering platform for individuals has now been embraced by the likes of lululemon, Neiman Marcus Group, Airbnb, and other industry and impact-leading companies. 🎁 Deed is an all-in-one social impact platform that provides companies with one exceptionally designed home for all of their employee engagement and purpose-driven activities: Workplace giving and donation matching, employee volunteer programs, corporate grantmaking, employee resource groups (ERGs), and more. Here’s to giving back, one deed at a time! Explore photos below of Deed initiatives in action. Cc: Paul Klemm, Jay Anna Harris-Theis, Elisheva Marcus, Rylee Mora, Deevee Kashi, Aske Ertmann, Steven L., Chad Haertling, Layle-Stav Kashi, Christine Tringale #Innovation #Startups #Tech4Impact #TechEmpowerment #FutureForward #EBVCgang

🧲 Slush has an undeniable magnetism, and the side events are a big reason why. We always look forward to our annual dinner with our friends at IVP, where we share portfolio companies and values. This year the central vibe was optimism despite all odds. 🍽️ We gathered at Robusto in Helsinki for connections and conversations. Thanks to our growing ecosystem of startups, investors, LPs, journalists, and tech supporters for joining us! 👀 We look forward to the next memorable visit. Enjoy a glimpse of the evening below. With: Dr. Christian Nagel, Paul Klemm, Tim Rehder, Vincenzo Narciso, Elle Muller, Eric Liaw, & many more #Slush24 #IVP #EBVCteam #Europe #Optimism #TechEcosystem #Helsinki #VC

🏆 This week, our portfolio company N26 announced its first quarterly profit, revealed that monthly signups have surpassed 200K and projected a 40% revenue growth in 2024, reaching approximately €440M. As an early backer, Earlybird Co-founder and Partner Dr. Christian Nagel witnessed N26’s growth from a teen-focused banking product to a leading digital bank in Europe. Recently, N26 hosted their L26 Leadership Strategy Day, bringing together their leadership community to share insights on top management. There Christian joined a fireside chat with N26 Founder Valentin Stalf. He shared how he saw the founders' potential early on—their resilience in overcoming obstacles was key. 🙌 Christian noted when they saw a door close, the team found a way to open it. We’re excited to watch the N26 team continue to level up, open new doors, and unlock the path to continued success. Read more about N26’s latest news in Sifted by Miriam Partington, linked in the comments section below. Cc: Maximilian Tayenthal, Crystal Goh, Scott Usatorres #NeoBank #FinTech #VC #Earlystage #Startups

Earlybird Health portfolio company Priothera SAS is preparing for a €60M capital raise to advance its promising drug candidate, mocravimod, treating blood and bone marrow cancers, including acute myeloid leukemia (AML). Mocravimod has shown the potential to improve AML patients’ survival rates by up to 40% two years after stem cell transplantation, while also reducing severe complications such as graft-vs-host disease (where the graft turns against the host and attacks its tissues). The funds will support the ongoing Phase III study, expected to deliver results in 2026, and drive expansion into other cancer types. With marketing approval targeted for 2027 and a projected penetration rate of 70%, mocravimod addresses a potential market of $1-2 billion across Europe, Japan, and the U.S. This technology represents a major step forward in transforming treatment outcomes for AML patients and beyond. ✍️ Read more in BIOTECHFINANCES by Pierre Havez. (🇫🇷 French) Cc: Florent Gros, Rabab Nasrallah, PhD, Valeriya S.

🇪🇺 Now is a critical moment to advance Europe’s technological sovereignty – to close the innovation gap, and to foster trusted alliances. Breakthrough technologies in GenAI, Life Sciences, Robotics, and SpaceTech are reshaping industries. Yet for European Deep Tech startups to compete on the global stage, they need greater access to customers and capital. This is why, together with the Deep Tech Momentum (DTM) team, we are committed to transforming Europe into one of the leading global Deep Tech ecosystems by supporting the continent’s most promising founders. Join DTM25 in Berlin from 13-15 May 2025 to drive Europe’s technological sovereignty forward! Read more about what DTM’s Martin Schilling and Isabelle Flanagan (pictured below) have been working on over the years and in stealth, in a Tech.eu article by Cate Lawrence linked in comments. Cc: Dr. Christian Nagel, Dr. Hendrik Brandis, Dr. Moritz Belling, Dr. Marie-Thérèse Buttlar, Alessandra Mazzilli, Elisheva Marcus, Rylee Mora #DeepTech #DTM25 #TechSovereignty #DeepTechMomentum #Berlin

⚛️ Recently, Earlybirds collaborated with Kearney in a series on the potential of quantum technologies. The latest article in the series focuses on how enterprises could benefit from the next-generation of ultra-precise monitoring tools. Whether that's in transportation, mining, healthcare, or environmental monitoring, the use cases seem limitless. 🏃♀️ Quantum sensing isn’t just a step forward—it’s a leap that promises to redefine precision in countless sectors. We’re excited to be part of this journey, by backing companies like QuantumDiamonds and eleQtron GmbH. For a deeper understanding of how quantum sensors work, recent advancements in the field, and tips for how enterprises can prepare dive into the article linked below. 🔗 https://bit.ly/4hQGm5I Cc: Dr. Frédéric du Bois-Reymond, Stephan Rauscher, Michael Römer, Dieter Gerdemann #Quantum #Startups #Advancements #DeepTech #VC #Investments

🇬🇧 Looking to kickstart your career in venture capital? Join our London office as an Analyst Intern in January 2025! If you have a passion for the European startup ecosystem and want to gain valuable experience in venture capital, this is your opportunity. We’re seeking an Analyst Intern to join our Investment team in London for 6 months, starting in January 2025. In this role, you will have the opportunity to… 💰 Support the deal flow process—sourcing startups, evaluating opportunities, and assisting with due diligence. 🔎 Conduct in-depth research and provide strategic insights to help inform investment decisions. 🌍 Expand your professional network across the European VC landscape, engaging with top founders, investors, and entrepreneurs. Applications are open now - Don’t miss the chance to make an impact and grow with us in London! If you’re ready to apply, head to the link in the comments section. Cc: Laura Waldenstrom, Akash Bajwa, Jay Anna Harris-Theis, Elisheva Marcus, Annika Schienbein, Rylee Mora #VentureCapital #Internship #London